CD91.DE vs. SPMO
CD91.DE (Amundi NYSE Arca Gold Bugs UCITS ETF Dist) and SPMO (Invesco S&P 500 Momentum ETF) are both exchange-traded funds - CD91.DE is a Gold fund tracking the NYSE Arca Gold BUGS, while SPMO is a Momentum fund tracking the S&P 500 Momentum Index. Both are passively managed. Over the past 10 years, CD91.DE returned 12.49%/yr vs 20.51%/yr for SPMO. At a 0.02 correlation, their price movements are largely independent. CD91.DE charges 0.65%/yr vs 0.13%/yr for SPMO.
Performance
CD91.DE vs. SPMO - Performance Comparison
Loading charts...
Different Trading Currencies
CD91.DE is traded in EUR, while SPMO is traded in USD. To make them comparable, the SPMO values have been converted to EUR using the latest available exchange rates.
Returns By Period
In the year-to-date period, CD91.DE achieves a 2.09% return, which is significantly lower than SPMO's 29.91% return. Over the past 10 years, CD91.DE has underperformed SPMO with an annualized return of 12.49%, while SPMO has yielded a comparatively higher 20.51% annualized return.
CD91.DE
- 1D
- 0.92%
- 1M
- -0.47%
- YTD
- 2.09%
- 6M
- 9.79%
- 1Y
- 67.95%
- 3Y*
- 40.18%
- 5Y*
- 20.17%
- 10Y*
- 12.49%
SPMO
- 1D
- -1.59%
- 1M
- 11.58%
- YTD
- 29.91%
- 6M
- 27.84%
- 1Y
- 41.51%
- 3Y*
- 38.49%
- 5Y*
- 25.07%
- 10Y*
- 20.51%
CD91.DE vs. SPMO - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
CD91.DE Amundi NYSE Arca Gold Bugs UCITS ETF Dist | 2.09% | 132.40% | 20.73% | 2.42% | -1.60% | -8.06% | 15.38% | 49.81% | -12.27% | -11.24% |
SPMO Invesco S&P 500 Momentum ETF | 29.91% | 11.56% | 55.44% | 14.03% | -4.90% | 31.82% | 17.68% | 28.77% | 3.73% | 12.06% |
Correlation
The correlation between CD91.DE and SPMO is 0.13, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.13 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.04 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.03 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.02 |
Correlation (All Time) Calculated using the full available price history since Oct 13, 2015 | 0.02 |
The correlation between CD91.DE and SPMO shifts across timeframes, from 0.02 (all time) to 0.13 (1 year), reflecting how their relationship changes across market environments.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
CD91.DE vs. SPMO — Risk / Return Rank
CD91.DE
SPMO
CD91.DE vs. SPMO - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Amundi NYSE Arca Gold Bugs UCITS ETF Dist (CD91.DE) and Invesco S&P 500 Momentum ETF (SPMO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| CD91.DE | SPMO | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.75 | ||
| Sortino ratioReturn per unit of downside risk | -1.00 | ||
| Omega ratioGain probability vs. loss probability | 1.27 | 1.41 | -0.15 |
| Calmar ratioReturn relative to maximum drawdown | 2.49 | 3.59 | -1.10 |
| Martin ratioReturn relative to average drawdown | 6.17 | 11.70 | -5.53 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| CD91.DE | SPMO | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.60 | 2.35 | -0.75 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.58 | 1.29 | -0.71 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.36 | 0.99 | -0.62 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.09 | 0.96 | -0.87 |
Drawdowns
CD91.DE vs. SPMO - Drawdown Comparison
The maximum CD91.DE drawdown since its inception was -80.32%, which is greater than SPMO's maximum drawdown of -32.02%. Use the drawdown chart below to compare losses from any high point for CD91.DE and SPMO.
Loading charts...
Drawdown Indicators
| CD91.DE | SPMO | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -80.32% | -32.02% | -48.30% |
Max Drawdown (1Y)Largest decline over 1 year | -27.16% | -11.63% | -15.53% |
Max Drawdown (3Y)Largest decline over 3 years | -27.16% | -25.02% | -2.14% |
Max Drawdown (5Y)Largest decline over 5 years | -39.56% | -25.02% | -14.54% |
Max Drawdown (10Y)Largest decline over 10 years | -55.46% | -32.02% | -23.44% |
Current DrawdownCurrent decline from peak | -23.41% | -1.59% | -21.82% |
Average DrawdownAverage peak-to-trough decline | -46.60% | -4.51% | -42.09% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 10.95% | 3.56% | +7.39% |
Volatility
CD91.DE vs. SPMO - Volatility Comparison
Amundi NYSE Arca Gold Bugs UCITS ETF Dist (CD91.DE) has a higher volatility of 13.40% compared to Invesco S&P 500 Momentum ETF (SPMO) at 6.79%. This indicates that CD91.DE's price experiences larger fluctuations and is considered to be riskier than SPMO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| CD91.DE | SPMO | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 13.40% | 6.79% | +6.61% |
Volatility (6M)Calculated over the trailing 6-month period | 33.89% | 13.70% | +20.19% |
Volatility (1Y)Calculated over the trailing 1-year period | 42.29% | 17.73% | +24.56% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 34.31% | 19.48% | +14.83% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 34.40% | 20.88% | +13.52% |
CD91.DE vs. SPMO - Expense Ratio Comparison
CD91.DE has a 0.65% expense ratio, which is higher than SPMO's 0.13% expense ratio.
Dividends
CD91.DE vs. SPMO - Dividend Comparison
CD91.DE's dividend yield for the trailing twelve months is around 0.13%, less than SPMO's 0.66% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CD91.DE Amundi NYSE Arca Gold Bugs UCITS ETF Dist | 0.13% | 0.14% | 0.31% | 2.37% | 1.05% | 0.46% | 0.14% | 0.30% | 0.00% | 0.57% | 0.00% | 0.00% |
SPMO Invesco S&P 500 Momentum ETF | 0.66% | 0.73% | 0.48% | 1.63% | 1.66% | 0.52% | 1.27% | 1.39% | 1.05% | 0.77% | 1.94% | 0.36% |
Frequently Asked Questions
CD91.DE and SPMO have a correlation of 0.13, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, SPMO is cheaper at 0.13% per year. The better choice depends on whether you care most about return, fees, risk, or income.
SPMO is cheaper with a 0.13% expense ratio, compared with 0.65% for CD91.DE.
CD91.DE is categorized as Gold, while SPMO is Momentum. CD91.DE tracks NYSE Arca Gold BUGS, while SPMO tracks S&P 500 Momentum Index. They also come from different issuers: Amundi and Invesco. Their fees differ too: 0.65% for CD91.DE and 0.13% for SPMO.
Find the right allocation for CD91.DE and SPMO
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer